[
  {
    "claim_i_idx": 4,
    "claim_j_idx": 0,
    "delta_prob": 0.6,
    "reasoning": "Rapid clinical timelines and parallelized trials make 5\u201310-year compression of bio/med progress more plausible."
  },
  {
    "claim_i_idx": 4,
    "claim_j_idx": 1,
    "delta_prob": 0.2,
    "reasoning": "Achieving year-scale clinical development implies very capable AI systems, nudging toward the 'country of geniuses' definition."
  },
  {
    "claim_i_idx": 4,
    "claim_j_idx": 2,
    "delta_prob": 0.3,
    "reasoning": "Using simulations/preclinical models to route around human-trial bottlenecks exemplifies intelligence navigating constraints."
  },
  {
    "claim_i_idx": 4,
    "claim_j_idx": 3,
    "delta_prob": 0.4,
    "reasoning": "Faster validation/iteration enables quicker discovery and deployment of general-purpose biological tools."
  },
  {
    "claim_i_idx": 4,
    "claim_j_idx": 5,
    "delta_prob": 0.2,
    "reasoning": "Shorter clinical cycles make aggressive health outcomes more plausible, though not guaranteed by clinical speed alone."
  },
  {
    "claim_i_idx": 4,
    "claim_j_idx": 6,
    "delta_prob": 0.3,
    "reasoning": "The same AI-driven acceleration and modeling should translate to neuroscience drug/dev cycles and measurement tech."
  },
  {
    "claim_i_idx": 4,
    "claim_j_idx": 7,
    "delta_prob": 0.15,
    "reasoning": "More effective interventions sooner increases the payoff of distribution campaigns, though logistics/politics remain key."
  },
  {
    "claim_i_idx": 4,
    "claim_j_idx": 8,
    "delta_prob": 0.1,
    "reasoning": "Better, faster health interventions can raise productivity and growth, but macroeconomic outcomes hinge on many other factors."
  },
  {
    "claim_i_idx": 4,
    "claim_j_idx": 9,
    "delta_prob": 0.0,
    "reasoning": "Clinical acceleration does not inform comparative regime advantages or grand strategy."
  },
  {
    "claim_i_idx": 4,
    "claim_j_idx": 10,
    "delta_prob": 0.0,
    "reasoning": "Biomedical acceleration is orthogonal to AI\u2019s effects on democratic governance tools."
  },
  {
    "claim_i_idx": 4,
    "claim_j_idx": 11,
    "delta_prob": 0.15,
    "reasoning": "Automating high-skill biomedical work supports the view that AI erodes labor\u2019s centrality over time."
  },
  {
    "claim_i_idx": 4,
    "claim_j_idx": 12,
    "delta_prob": 0.15,
    "reasoning": "A major near-term capability jump in biomed is evidence consistent with a 'gentle singularity' underway."
  },
  {
    "claim_i_idx": 4,
    "claim_j_idx": 13,
    "delta_prob": 0.1,
    "reasoning": "If such biomedical capabilities arrive soon, near-term timelines for broader AI progress look slightly more credible."
  },
  {
    "claim_i_idx": 4,
    "claim_j_idx": 14,
    "delta_prob": 0.35,
    "reasoning": "Compressing R&D cycles via AI and simulations is a concrete form of research acceleration akin to recursive improvement."
  },
  {
    "claim_i_idx": 4,
    "claim_j_idx": 15,
    "delta_prob": 0.1,
    "reasoning": "High ROI from accelerated biomed nudges investment and infrastructure flywheels, though only modestly on its own."
  },
  {
    "claim_i_idx": 4,
    "claim_j_idx": 16,
    "delta_prob": 0.0,
    "reasoning": "Clinical acceleration does not directly bear on scaling laws or unit-cost trends."
  },
  {
    "claim_i_idx": 4,
    "claim_j_idx": 17,
    "delta_prob": 0.2,
    "reasoning": "Year-scale clinical development implies AI agents functioning as capable virtual coworkers in complex domains."
  },
  {
    "claim_i_idx": 4,
    "claim_j_idx": 18,
    "delta_prob": 0.1,
    "reasoning": "Faster medical progress fits a world that feels familiar yet far more capable by the 2030s."
  },
  {
    "claim_i_idx": 4,
    "claim_j_idx": 19,
    "delta_prob": 0.3,
    "reasoning": "This is a salient example of dramatic acceleration in science amid uneven industry change."
  },
  {
    "claim_i_idx": 4,
    "claim_j_idx": 20,
    "delta_prob": 0.0,
    "reasoning": "The claim doesn\u2019t address alignment or safety requirements."
  },
  {
    "claim_i_idx": 4,
    "claim_j_idx": 21,
    "delta_prob": 0.0,
    "reasoning": "No direct link between faster clinical development and policy orientation toward individual empowerment."
  },
  {
    "claim_i_idx": 4,
    "claim_j_idx": 22,
    "delta_prob": 0.1,
    "reasoning": "Transformative medical gains heighten the importance of broad benefit distribution mechanisms."
  },
  {
    "claim_i_idx": 4,
    "claim_j_idx": 23,
    "delta_prob": 0.2,
    "reasoning": "Such biomed capabilities suggest a trajectory toward widely accessible, on-demand high-level expertise by ~2035."
  }
]